News
-
Join Marco & Micro-Test at MEDICA 2025 in Düsseldorf, Germany!
From November 17 to 20, 2025, the global healthcare industry will once again gather in Düsseldorf, Germany, for one of the largest medical trade fairs in the world – MEDICA 2025. This prestigious event will feature over 5,000 exhibitors from nearly 70 countries, and over 80,000 professional visit...Read more -
Urgent Action Against Influenza! Macro & Micro-Test Delivers Reliable Protection
The global spread of highly pathogenic H5 avian influenza continues to intensify. Across Europe, outbreaks have surged, with Germany alone culling nearly one million birds. In the United States, two million egg-laying hens have been destroyed due to infection, and H5N1 has now been detected in da...Read more -
The Critical Role of Biomarker Testing in Top Cancer Killer
According to the latest global cancer report, lung cancer continues to be the foremost cause of cancer-related deaths worldwide, accounting for 18.7% of all such fatalities in 2022. The vast majority of these cases are Non-Small Cell Lung Cancer (NSCLC). While the historical reliance on chemother...Read more -
WHO EUL-Approved Monkeypox Test: Your Partner in Sustained Mpox Surveillance and Reliable Diagnosis
As monkeypox continues to pose a global health challenge, having a diagnostic tool that is both trustworthy and efficient has never been more critical. Jiangsu Macro & Micro-Test Med-Tech is proud to announce that our Monkeypox Virus Nucleic Acid Detection Kit (Fluorescence PCR) has been sele...Read more -
Understanding HPV and the Power of HPV 28 Typing Detection
What is HPV? Human Papillomavirus (HPV) is one of the most common sexually transmitted infections (STIs) globally. It’s a group of more than 200 related viruses, and about 40 of them can infect the genital area, mouth, or throat. Some HPV types are harmless, while others can cause serious h...Read more -
Stay Ahead of Respiratory Infections: Cutting-Edge Multiplex Diagnostics for Rapid and Accurate Solutions
As the autumn and winter seasons arrive, bringing a sharp drop in temperatures, we enter a period of high incidence for respiratory infections—a persistent and formidable challenge to global public health. These infections range from the frequent colds that trouble young children to severe pneumo...Read more -
Targeting NSCLC: Key Biomarkers Revealed
Lung cancer remains a leading cause of cancer-related mortality worldwide, with Non-Small Cell Lung Cancer (NSCLC) accounting for approximately 85% of all cases. For decades, the treatment of advanced NSCLC relied primarily on chemotherapy, a blunt instrument that offered limited efficacy and sig...Read more -
Unlocking Precision Medicine in Colorectal Cancer: Master KRAS Mutation Testing with Our Advanced Solution
Point mutations in the KRAS gene are implicated in a range of human tumors, with mutation rates of approximately 17%–25% across tumor types, 15%–30% in lung cancer, and 20%–50% in colorectal cancer. These mutations drive treatment resistance and tumor progression through a key mechanism: the P21 ...Read more -
Precision Management of CML: The Critical Role of BCR-ABL Detection in the TKI Era
Chronic Myelogenous Leukemia (CML) management has been revolutionized by Tyrosine Kinase Inhibitors (TKIs), turning a once-fatal disease into a manageable chronic condition. At the heart of this success story lies precise and reliable monitoring of the BCR-ABL fusion gene—the definitive molecular...Read more -
Unlock Precision Treatment for NSCLC with Advanced EGFR Mutation Testing
Lung cancer remains a global health challenge, ranking as the second most commonly diagnosed cancer. In 2020 alone, there were over 2.2 million new cases worldwide. Non-small cell lung cancer (NSCLC) represents more than 80% of all lung cancer diagnoses, highlighting the urgent need for targeted ...Read more -
MRSA: A Growing Global Health Threat – How Advanced Detection Can Help
The Rising Challenge of Antimicrobial Resistance The rapid growth of antimicrobial resistance (AMR) represents one of the most serious global health challenges of our time. Among these resistant pathogens, Methicillin-Resistant Staphylococcus Aureus (MRSA) has emerged as...Read more -
Reflecting on Our Success at Medical Fair Thailand 2025 Dear Valued Partners and Attendees,
As Medlab Middle East 2025 has just come to a close, we take this opportunity to reflect on a truly remarkable event. Your support and engagement made it a tremendous success, and we are grateful for the opportunity to showcase our latest innovations and exchange insights with industry leaders. ...Read more